Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Haque, Tanzina; Wilkie, Gwen M; Jones, Marie M; Higgins, Craig D; Urquhart, Gillian; Wingate, Phoebe; Burns, David; McAulay, Karen; Turner, Marc; Bellamy, Christopher; +6 more... Amlot, Peter L; Kelly, Deirdre; MacGilchrist, Alastair; Gandhi, Maher K; Swerdlow, Anthony J; Crawford, Dorothy H; (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, 110 (4). pp. 1123-1131. ISSN 0006-4971 DOI: https://doi.org/10.1182/blood-2006-12-063008

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1182/blood-2006-12-063008

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar